Patent ID: 6262093
Filing Date: 2001-07-17
Classification: A61K

Abstract:
A method of treating cancer selected from the group consisting of carcinoma, sarcoma, and lymphoma, the method comprising administering to a patient in need thereof a therapeutically effective amount of a composition comprising a benzimidazole compound of the formula: ##STR6##wherein,X is hydrogen, halogen, alkyl of less than 7 carbon atoms, or alkoxy of less than 7 carbon atoms;n is a positive integer of less than 4;Y is hydrogen, chloro, nitro, methyl, ethyl, or oxychloro;R is hydrogen, an alkyl group of from 1 to 8 carbon atoms, or alkylaminocarbonyl wherein the alkyl group has from 3 to 6 carbon atoms; andR.sub.2 is NHCOOR.sub.1, wherein R.sub.1 is an aliphatic hydrocarbon of less than 7 carbon atoms;or a prodrug thereof, a pharmaceutically acceptable salt thereof, or mixtures thereof.